Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.34 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7603513 | 0.94 | LMNA (0.48) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL7609993 | 0.92 | LMNA (0.52) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL1001384 | 0.88 | LMNA (0.39) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL10554751 | 0.87 | LMNA (0.57) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL6231000 | 0.87 | LMNA (0.52) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL7768019 | 0.85 | LMNA (0.61) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL11041078 | 0.85 | LMNA (0.61) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL2988368 | 0.83 | LMNA (0.59) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL2689971 | 0.83 | LMNA (0.59) | LMNAEPHX2MAPTMAPK1ALDH1A1 | |
| SCHEMBL2982658 | 0.83 | LMNA (0.59) | LMNAEPHX2MAPTMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2244710-A1 | A METHOD OF ADMINISTERING A PDE3 INHIBITOR VIA TITRATION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE | Indigo Pharmaceuticals (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2010099388-A1 | COMBINATIONAL USE OF A PDE3 INHIBITOR AND OTHER AGENTS | INDIGO PHARMACEUTICALS (US) | 2010-09-02 | — | — | WO | disclosed |
| US-7767624-B2 | 3-Heterocyclyl substituted benzoic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| WO-2009097406-A1 | A METHOD OF ADMINISTERING A PDE3 INHIBITOR VIA TITRATION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE | INDIGO PHARMACEUTICALS (US) | 2009-08-06 | — | — | WO | disclosed |
| EP-1527052-B1 | 3-HETEROCYCLYL SUBSTITUTED BENZOIC ACID DERIVATIVES | BASF AG (DE) | 2006-05-31 | — | — | EP | disclosed |
| US-20050239655-A1 | 3-heterocyclyl substituted benzoic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-27 | — | — | US | disclosed |
| US-6956034-B2 | Oxazin(ethyl)one compounds used as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-18 | — | — | US | disclosed |
| EP-1395570-B1 | OXAZIN(THI)ONE COMPOUNDS USED AS FUNGICIDES | BASF AG (DE) | 2005-08-10 | — | — | EP | disclosed |
| US-6888003-B2 | Method for producing 7-(pyrazole-3-yl) benzoxazoles | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-03 | — | — | US | disclosed |
| US-20040248981-A1 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-12-09 | — | — | US | disclosed |
| WO-1998020000-A2 | SUBSTITUTED 3-BENZYLPYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1998-05-14 | — | — | WO | disclosed |
| WO-1998007700-A1 | SUBSTITUTED 2-PHENYLPYRIDINE AS HERBICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1998-02-26 | — | — | WO | disclosed |
| WO-1998007720-A1 | SUBSTITUTED 2-ARYLPYRIDINE AS HERBICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1998-02-26 | — | — | WO | disclosed |
| WO-1997015559-A1 | SUBSTITUTED 4,5-DI(TRIFLUOROMETHYL)PYRAZOLES AND THEIR USE AS HERBICIDES AND FOR DESICCATING/DEFOLIATING PLANTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-01 | — | — | WO | disclosed |
| WO-1997011059-A1 | SUBSTITUTED 2-PHENYLPYRIDINES AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-27 | — | — | WO | disclosed |
| EP-0721454-A1 | NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST | J. URIACH & CIA. S.A. (ES) | 1996-07-17 | — | — | EP | disclosed |
| US-5318968-A | Antithrombotic agents; cardiotonic agents; vasodilators | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-06-07 | — | — | US | disclosed |
| US-5314883-A | Vasodilation, anticoagulants | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-05-24 | — | — | US | disclosed |
| US-5202323-A | Antithrombotic, inotropic, vasodilator, antiallergen | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-04-13 | — | — | US | disclosed |
| EP-0482208-A1 | PYRIDAZINONE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239655-A1 | 3-heterocyclyl substituted benzoic acid derivatives | DDT, CBR3, BROX | LMNA 3577/4885EPHX2 898/4885MAPT 4741/4885 |
| US-20040248981-A1 | Benzamidine derivatives | HABP2, F7, F2 | LMNA 1715/4885EPHX2 3822/4885MAPT 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.